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Abstract—Fourier transform infrared (FTIR) spectroscopy is
evaluated as a tool to monitor two bacterial processes: strain
discrimination and drug inactivation studies with the gastric
pathogen Helicobacter pylori and the plasmid production process
based on high-density cultures of recombinant Escherichia coli.
Results show, that after evaluation of different incubation condi-
tions of H.pylori with the drug model, the application of principal
component analysis to the FTIR spectra assembles the samples
into clusters which can be related with the minimal inhibitory
concentration. Morever, the same methodology applied to FTIR
spectra from 12 different strains can be used to distinguish them.
For the E.coli cultures it is possible to estimate the concentration
of relevant bioprocess monitoring variables, such as plasmid,
biomass, and carbon sources (glucose, glycerol, acetate) by using
partial least squares (PLS) models based on FTIR spectra.
Index Terms—FTIR spectroscopy; chemometrics; H.pylori;
E.coli; drug inactivation; bioprocess monitoring;
I. INTRODUCTION
Fourier transform infrared (FTIR) spectroscopy is becoming
an interesting technique to monitor and analyse biological
processes due to recent developments in FTIR spectroscopy
instrumentation, which increased wavelength accuracy, spec-
tral quality and reproducibility [1]. It has been applied in
many biological areas, as for example in discrimination of
the pathogen Straphylococcus aureus from other strains of
Straphylococcus [2], to detect intracellular components, such
as granules, capsules and endospores in intact bacteria [3] and
to identify the signature of the metabolic changes in prostate
cancer cells induced by anticancer drugs [4].
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FTIR spectroscopy usually allows rapid non destructive analy-
sis requiring minimal sample preparation. By applying several
preprocessing techniques and chemometric methods, such as
principal component analysis and partial least squares re-
gression, it is possible to process FTIR spectra and extract
biologically meaningful information. This work studies the
applicability of FTIR spectroscopy in two different bacterial
processes: strain discrimination (A) and drug inactivation
studies (B) with the gastric pathogen H.pylori and the plasmid
production process based on high-density cultures of recom-
binant E.coli (C).
A. Discrimination of 12 H.pylori strains
H.pylori, a Gram-negative microaerophilic bacterium highly
adapted for colonization of the human stomach, infects more
than half of the world’s human population, contributing to
several gastric diseases such as peptic ulcer, MALT lymphoma
or gastric carcinoma [5]–[7]. As it presents a high genetic
variability [8], [9], patients are often infected with multiple
H.pylori strains [10]. Eradication therapy generally includes
two or more antimicrobials, but resistances of some strains
against the most commonly used antibiotics can lead to
a failure of the treatment. Moreover, many broad-spectrum
antibiotics are expensive and have toxic side effects [11]. For
these reasons a rapid identification of the present H.pylori
strains is desirable in order to provide an effective therapy.
This thesis investigates the potential of FTIR spectroscopy to
distinguish 12 H.pylori strains.
B. The drug inactivation of the gastric pathogen H.pylori
The gastric pathogen H.pylori is usually acquired in early
childhood [10] and if not treated with antibiotics persists
TABLE I
MAIN CHARACTERISTICS OF FIVE DIFFERENT SETS OF EXPERIMENTS CONDUCTED WITH H.pylori STRAINS 26695 AND J99, DIFFERING IN RELATION TO
THE QUANTITY OF THE BACTERIA AND THE NUTRIENT BRUCELLA BROTH IN THE FINAL INCUBATION MIXTURE AS WELL AS THE TIME USED FOR
INCUBATION OF THE BACTERIA WITH THE DRUG MODEL. THE INCUBATION MIXTURES OF EXPERIMENTS 2 TO 5 WERE WASHED PRIOR TO SPECTRA
ACQUISITION IN CONTRAST TO EXPERIMENT 1.
H.pylori
strain
Experiment
number
OD Brucella
broth
Tested drug concentration
(µg ml−1)
Incubation
time (h)
Analyte vol-
ume (µl)
Sample type
26695
1 4 25% 0,2.5,25,50,75,100 1 30 whole incubation mixture
2 2 5% 0,2.5,5,25,50,75,100,200,400 1 25 washed cells
3 2 5% 0,2.5,5,25,50,75,100,200,400 3 25 washed cells
4 2 5% 0,2.5,5,25,50,75,100,200,400 6 25 washed cells
J99 5 4 0 0,2.5,25,50,75,100,200 1 25 washed cells
throughout life. Unfortunately, eradication therapy fails in
10 to 20% of all cases due to growing resistances against
the commonly used antibiotics, such as metronidazole and
clarithromycin. To overcome these limitations it is crucial
to screen for new antibacterial drugs, which in the case of
H.pylori is difficult due to the high genetic variability of
this organism [8], [9]. Therefore a high-throughput method
is needed for the drug screening. This thesis evaluates the
potential of FTIR spectroscopy as a technique to monitor the
effect of a drug model on the bacterium metabolism, which
could be used in future high-throughput drug screenings.
C. The plasmid production process based on high-density
cultures of recombinant E.coli
In the last decade plasmid vectors have become extremely
attractive for use in DNA vaccines and gene therapy, as
they offer multiple advantages over viral vectors, including
large packaging capacity, stability without integration and
reduced toxicity [12]. However, the industrial plasmid pro-
duction with recombinant E.coli cells is a complex process, as
many parameters, such as medium composition and cultivation
conditions influence the plasmid copy number, stability and the
amount of biomass produced [13]. Therefore it is crucial to
develop monitoring techniques which allow to increase the
understanding of the process, its control and optimisation.
Conventional laboratory methods are usually not adequate to
measure the significant parameters in a time frame which
allows adjustments of the process [14]. Therefore it is relevant
to develop rapid monitoring techniques, which give informa-
tion about the culture state to adjust the characteristics of the
culture improving batch to batch reproducibility as well as
process efficiency. Being a rapid and sensitive analysis method,
FTIR spectroscopy is promising to serve well for this purpose.
This thesis evaluates it as a tool to predict the concentration
of the relevant variables for control and optimisation of the
cultivation bioprocess, which are biomass, plasmid and carbon
sources (glucose, glycerol, acetate).
II. GOALS
This thesis aims at monitoring the drug inactivation of
H.pylori by FTIR spectroscopy to determine if this method
can serve as a quick alternative to conventional drug suscepti-
bility assays. Moreover, the potential of FTIR spectroscopy in
discriminating 12 H.pylori strains is investigated. Furthermore,
FTIR spectroscopy is evaluated as a monitoring technique for
the plasmid bioproduction in recombinant E.coli cultures with
the objective of rapidly predicting the most relevant variables
for monitoring purposes: the concentration of biomass, plas-
mid and the carbon sources glucose, glycerol and acetate.
III. MATERIAL AND METHODS
A. Sample preparation for the H.pylori dataset
The minimum inhibitory concentration (MIC) was deter-
mined by J.Lopes and M.Oleastro using the agar dilution
method as recommended by the H.pylori study group [15]. To
evaluate if FTIR spectroscopy is capable to estimate the MIC
obtained by this conventional method, 5 sets of experiments
were conducted representing different incubation conditions
of the H.pylori strains with the drug model (table I). For this,
the bacterial strains J99 and 26695 were grown on H.pylori
selective media (Biogerm, Portugal) and incubated for 24 to
48 hours at 37◦C in microaerophilic conditions (CampyGen,
Oxoid, UK). The bacteria were collected from the petri dishes
and suspended in NaCl 0.9% (w/v). The optical density (OD)
of the resuspended cells was read at 600 nm (using Synergy 2,
BioTek Instruments in combination with the GEN5 software,
BioTek Instruments, USA) after appropriate dilution and the
incubation mixtures as described in table I were prepared.
For investigating the potential of FTIR spectroscopy to dis-
criminate between H.pylori strains, samples of the strains
4115, 3485, 4009, 3746, 3861, 26695, 3982, 4101, J99, 3551,
3923 and 4212 with an optical density of ca. 4 were prepared
as discribed above. Strains 26695, originally isolated from an
English patient suffering from gastritis [16] and strain J99,
obtained in the USA from a patient with a duodenal ulcer
[17] are reference strains. The remaining strains were isolated
in 2008 and 2009 from Portuguese patients and belong to the
collection of the National Institute of Health Dr. Ricardo Jorge
(Lisbon, Portugal).
B. Sample preparation for the E.coli dataset
Five E. coli batch cultures were conducted by Martins
(2009) [18] in non selective and complex media using yeast
extract and bacto tryptone as nitrogen sources and different
mixtures of glucose and glycerol as carbon sources (table II).
The concentration of biomass, plasmid, glucose, glycerol
and acetate were analysed by Martins (2009) [18] by high-
performance liquid chromatography (HPLC) and enzymatic
methods. The cellular E.coli pellets obtained from centrifuga-
tion of 1 ml of whole broth obtained along the five cultures
were resuspended in 5 ml of NaCl 0.9% (w/v) for the
subsequent FTIR analysis.
C. Spectra aquisition
For the FTIR analysis 25 or 30 µl of the bacterial cell
suspension were placed on IR-transparent Zn-Se-microtiter
plates with 96 wells (Bruker optics, Germany) and dehydrated
using a vacuum dessicator (ME2, Vaccubrand, Germany).
The FTIR spectra were acquired using a HTS-XT associated
to a Vertex-70 spectrometer (Bruker optics, Germany) at a
resolution of 2 cm−1. Each final spectrum results from the
average of 40 spectra acquisitions.
D. Preprocessing and multivariate data analysis
For both datasets several preprocessing strategies (offset
correction, spectra normalization, multiplicative scatter correc-
tion (MSC), first derivative and using a narrow region of the
spectra) have been tested. Manipulation of the spectra and the
application of the chemometric methods have been performed
with Matlab concerning the H.pylori dataset. For the E.coli
dataset additionally a baseline correction has been performed
using the OPUS software provided by Bruker.
IV. RESULTS AND DISCUSSION
A. Discrimination of H.pylori strains
FTIR spectroscopy provides a ”molecular fingerprint” of
the analysed cells and thus quantitative information about its
total biochemical composition [19], which can be used for
identification and discrimination of microorganisms [2]. To
evaluate the discriminatory power of FTIR spectroscopy, the
spectra of 12 H.pylori strains were collected and, thereafter,
processed using MSC. Afterwards, PCA was performed on the
first derivate of the spectra. In the score plot of the first two
principal components (fig. 1) it is possible to distinguish the
strains. It is worth to point out, that the two strains on which
the inactivation by a drug model was monitored in this thesis,
namely the strains J99 and 26695, are located in different areas
of the score plot, which indicates big structural differences.
B. Inactivation of H.pylori by a drug model
The minimal inhibitory concentration (MIC) of the
drug model, determined by the agar dilution method was
100 µg ml−1 for strains J99 and 26695. With the main
goal to evaluate, if the rapid and sensitive technique of FTIR
TABLE II
MEDIUM COMPOSITION IN CARBON SOURCE OF BATCH CULTURES A TO
E. THE VALUES WERE OBTAINED BY ANALYSES IN THE BIOREACTOR
IMMEDIATELY AFTER THE START OF THE CULTURE.
Batch Glucose (g l−1) Glycerol (g l−1)
A 6.0 0.0
B 0.0 5.1
C 6.8 5.4
D 4.1 5.4
E 8.8 3.9
Fig. 1. Score plot of the first two principal components of the spectra of
the H.pylori strains 4115, 3485, 4009, 3746, 3861, 26695, 3982, 4101, J99,
3551, 3923 and 4212.
spectroscopy could be used to monitor the H.pylori drug
inactivation in an alternative way, several experiments were
conducted as described in table I.
After evaluating the above mentioned preprocessing tech-
niques, for the principal component analysis on the H.pylori
dataset a preprocessing of offset correction and multiplicative
scatter correction (MSC) on the sample replicates has been
chosen. Moreover, the first derivative was calculated using
the Savitzky-Golay filter of window size 15 and polynomial
order 4.
The experiments on strain 26695 showed, that cell quantities
corresponding to an OD higher than 4 should be used, as lower
quantities result in low absorbance values in the spectra, which
decrease the signal to noise ratio (SNR). Moreover, brucella
broth absorbs in the IR region (data not shown) and thus the
cells should be washed before the spectra aquisition.
Principal component analysis showed, that FTIR spectroscopy
can be used to monitor the effect of the drug on the H.pylori
metabolism, even for concentrations far lower than the MIC
such as 2.5 µg ml−1 (fig. 2). The results regarding the analysis
of the FTIR datasets obtained from H.pylori strains 26695
(Experiment 2 and 4) and J99 (Experiment 5) will be presented
and discussed.
Fig. 2(a) shows a score plot of the first two principal compo-
nents (PCs) of the spectra of experiment 2. A clear division
into two groups is recognizable: One group contains the scores
representing samples incubated with a concentration of the
drug of 200 µg ml−1 or higher, the other group contains
all the other scores with no evident order related to the
drug concentrations used. This clustering indicates a severe
metabolic change in the bacteria for concentrations higher
than the MIC. Comparison with experiment 4, which differed
from experiment 2 only in the incubation period allows an
analysis of the drug’s effect over time of exposure. Using an
incubation time of 6 hours it is possible to detect a structure
in the score plot of the first two principal components of the
spectra, which is in accordance with the minimal inhibitory
concentration (fig. 2(b)). In this plot, three clusters are well
(a) Experiment 2 with an incubation time of 1 hour (b) Experiment 4 with an incubation time of 6 hours
Fig. 2. Score plots of the first two principal components of experiments 2 and 4 conducted on H.pylori strain 26695 using an incubation time of one and 6
hours, respectively.
defined:
• The cluster formed by the scores representing the control
sample, which was incubated without the drug.
• The cluster, which contains the scores representing the
bacteria incubated with the drug of concentrations from
2.5 up to 75 µg ml−1, which are below the MIC
(100 µg ml−1).
• The cluster composed of the scores representing the
bacteria incubated with the drug of concentrations of the
MIC or higher.
It can be concluded that after an incubation period of 6 hours,
FTIR spectroscopy detects metabolic changes induced by the
drug. For concentrations at or above 100 µg ml−1 there is
a clear change in the cellular metabolism, which is detected
in FTIR spectra by the PCA as a distinct cluster. Moreover
it is possible to identify the control sample, which shows,
that for this incubation time even small concentrations of the
drug, such as 2.5 µg ml−1 have an effect on the bactera’s
metabolism.
For the spectra obtained from this experiment, it was possible
to draw conclusions about the apparent translational level
of the bacteria. This was achieved by assignment of the the
peaks at wavenumbers 1660 and 1240 cm−1 to proteins and
genomic DNA [11] and estimation of the ratio of produced
proteins per genomic DNA. This ratio drops from 5.6 to 3.2
at the threshold of 100 µg ml−1 in accordance with the
minimal inhibitory concentration determined for this strain.
In experiment 5, the effect of the drug model has been
monitored on the metabolism of H.pylori strain J99, which
differs strongly from the strain 26695 in its molecular
fingerprint (fig. 1). The score plot of the first two PCs of
the spectra (fig. 3) shows three clusters: one containing
the scores representing the control sample and the sample
incubated with a drug concentration of 2.5 µg ml−1, one
containing the scores representing the samples incubated with
drug concentrations between 25 and 75 µg ml−1 and one
containing the scores, which represent the samples treated
with drug concentrations equal or higher than the MIC of
100 µg ml−1.
C. Recombinant E.coli batch cultures for plasmid production
PLS regression has been performed on the spectra of the
culture samples in order to predict the concentration of the
major variables of the batch cultivations, which are plasmids,
biomass, glucose, glycerol and acetate. Before this, the spectra
have been preprocessed with MSC on the sample replicates
and the first derivative, which has been calculated using the
Savitzky-Golay filter of window size 15 and order 4. Moreover
a smaller region of the spectra was chosen to build the models,
which was from wavenumbers 900 to 1900 cm−1.
To determine how many latent variables should be used for the
PLS model, a leave-one-out (LOO) cross-validation has been
performed. The predicted values, which were obtained by the
LOO cross-validation have been used to judge the quality of
calibration by calculating the correlation coefficient between
these values and the experimental ones. As an example, in the
following the estimation of the plasmid as well as the biomass
concentration will be discussed in detail.
The PLS model of the plasmid concentration, performed
on the spectra of all the batches using 17 latent variables
gave a correlation coefficient between the predicted and the
experimental values of 0.956, indicative of a good prediction
performance (fig. 4(a)). The present PLS model to predict the
plasmid concentration was developed considering the spectra
of all 5 batches. It is worth to mention, that the 5 batches
were conducted in different medium compositions resulting
in different culture behaviours. To evaluate the capacity of
monitoring plasmid production in a defined culture condition,
which usually occurs in industrial processes, the PLS model
was also developed for batch D. The correlation coefficient,
which resulted from this PLS using 9 latent variables, was
0.973, which is higher than the one using the spectra of all
cultures.
Economic large-scale plasmid production from E.coli requires
(a) Predicted and experimental values of the plasmid concentra-
tion
(b) Predicted and experimental values of the biomass concentra-
tion
Fig. 4. Predicted and experimental values of the PLS regression on the plasmid and the biomass concentration using 17 and 6 latent variables respectively.
The correlation coefficient between the predicted and the experimental values was 0.956 and 0.975 respectively.
Fig. 3. Score plot of the first two principal components of experiment 5
conducted on H.pylori strain J99, using different concentrations of the drug
and an incubation time of one hour.
the concomitant optimisation of plasmid copy number (specific
yield) and of biomass concentration [13]. Therefore it is
necessary to monitor the latter. In this thesis, a PLS regression
has been performed on the spectra of all the batches and using
the predicted values of the LOO cross-validation a correlation
coefficient of 0.975 could be obtained using 6 latent variables
(fig. 4(b)). For the other parameters of interest, namely acetate,
glucose and glycerol is was also possible to develop PLS
models with correlation coefficients higher than 0.95.
V. CONCLUSIONS
FTIR spectroscopy was evaluated for two bacterial
processes: strain discrimination and drug inactivation studies
with the gastric pathogen H.pylori and plasmid bioproduction
in recombinant E.coli cultures.
The application of several preprocessing techniques (offset
correction, spectra normalization, multiplicative scatter
correction (MSC), first derivative and using a narrow region
of the spectra) on the spectra showed, that preprocessing
highly influences the output of the subsequent data analysis.
Therefore, the preprocessing techniques must be selected
carefully.
Principal component analysis of the spectra collected from
12 different H.pylori strains showed, that FTIR spectroscopy
can be used as a tool for discriminating between different
bacterial strains and most probably the bacteria typing.
For the monitoring of the drug inactivation of H.pylori
several incubation conditions of the bacterium with the drug
model were evaluated: the drug concentration, the incubation
period, the presence and concentration of the nutrient broth,
the bacteria quantity and the bacterial strain. For all the
experiments it was possible to monitor the effect of the drug
on the bacteria, even for low drug concentrations, such as
2.5 µg ml−1. Moreover, the effect of the drug related to
the time of exposure could be studied. In summary, FTIR
spectroscopy can be used to estimate the H.pylori drug
inactivation in a rapid and sensitive way, using low quantities
of bacteria and the target drug in comparison to the ones
used in the conventional method of agar dilution. The E.coli
dataset was obtained by collecting the FTIR spectra of the
bacteria pellet throughout several batch cultivations using
different concentrations of glucose and glycerol as carbon
sources. From the FTIR spectra of the bacteria PLS regression
models were built to predict the plasmid concentration as
well as the concentration of the major metabolites of the
culture, namely biomass, glucose, glycerol and acetate. In all
PLS models, the leave-one-out cross-validation gave rise to
correlation coefficients higher than 0.95 between the predicted
and the experimental values, which indicates good prediction
performance.
ACKNOWLEDGMENT
This master thesis has been been financially supported by
the FCT research project PTDC/Bio/69242/2006.
REFERENCES
[1] J. Schmitt and H.-C. Flemming, “FTIR-spectroscopy in microbial and
material analysis,” International Biodeterioration & Biodegradation,
vol. 41, no. 1, pp. 1–11, 1998.
[2] H. Lamprell, G. Mazerolles, A. Kodjo, J. Chamba, Y. Nol, and E. Beu-
vier, “Discrimination of Staphylococcus aureus strains from different
species of Staphylococcus using fourier transform infrared (FTIR)
spectroscopy,” International Journal of Food Microbiology, vol. 108,
no. 1, pp. 125 – 129, 2006.
[3] D. Helm and D. Naumann, “Identification of some bacterial cell com-
ponents by FT-IR spectroscopy,” FEMS Microbiology Letters, vol. 126,
no. 1, pp. 75 – 79, 1995.
[4] R. Gasper, T. Mijatovic, A. Bnard, A. Derenne, R. Kiss, and E. Goor-
maghtigh, “FTIR spectral signature of the effect of cardiotonic steroids
with antitumoral properties on a prostate cancer cell line,” Biochimica et
Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1802, no. 11,
pp. 1087 – 1094, 2010.
[5] J. C. Atherton, “The pathogenesis of Helicobacter pylori-induced gastro-
duodenal diseases,” Annual Review of Pathology, vol. 1, pp. 63 – 96,
2006.
[6] S. Suerbaum and P. Michetti, “Helicobacter pylori infection,” The new
england journal of medicine, vol. 347, no. 15, pp. 1175 – 86, 2002.
[7] V. Babus, M. Strnad, V. Presecki, M. Katicic, S. Kalinic, and M. Balija,
“Helicobacter pylori and gastric cancer in croatia,” Cancer Letters, vol.
125, no. 1-2, pp. 9 – 15, 1998.
[8] M. J. Blaser and D. E. Berg, “Helicobacter pylori genetic diversity and
risk of human disease,” Journal of clinical investigation, vol. 107, no. 7,
pp. 767 – 73, 2001.
[9] S. Suerbaum and C. Josenhans, “Helicobacter pylori evolution and phe-
notypic diversification in a changing host,” Nature reviews microbiology,
vol. 5, no. 6, pp. 441 – 52, 2007.
[10] T. L. Cover and M. J. Blaser, “Helicobacter pylori in health and disease,”
Gastroenterology, vol. 136, no. 6, pp. 1863 – 1873, 2009.
[11] K. Maquelin, C. Kirschner, L. P. Choo-Smith, N. van den Braak, H. P.
Endtz, D. Naumann, and G. J. Puppels, “Identification of medically
relevant microorganisms by vibrational spectroscopy.” Journal of Mi-
crobiological Methods, vol. 51, no. 3, pp. 255 – 271, 2002.
[12] T. Silva, P. Lima, M. Roxo-Rosa, S. Hageman, L. P. Fonseca, and
C. R. C. Calado, “Prediction of dynamic plasmid production by recombi-
nant Escherichia coli fed-batch cultivations with a generalized regression
neural network,” Chemical and Biochemical Engineering Quarterly,
vol. 23, no. 4, 2009.
[13] K. J. Prather, S. Sagar, J. Murphy, and M. Chartrain, “Industrial scale
production of plasmid dna for vaccine and gene therapy: plasmid
design, production, and purification,” Enzyme and Microbial Technology,
vol. 33, no. 7, pp. 865 – 883, 2003.
[14] S. Sivakesava, J. Irudayaraj, and D. Ali, “Simultaneous determination
of multiple components in lactic acid fermentation using FT-MIR, NIR,
and FT-Raman spectroscopic techniques,” Process Biochemistry, vol. 37,
no. 4, pp. 371 – 378, 2001.
[15] F. Me´graud and P. Lehours, “Helicobacter pylori detection and antimi-
crobial susceptibility testing,” Clinical Microbiology Review, vol. 20,
no. 2, pp. 280 – 322, 2007.
[16] J. Tomb, O. White, A. Kerlavage, R. Clayton, G. Sutton, R. Fleischmann,
K. Ketchum, H. Klenk, S. Gill, B. Dougherty, K. Nelson, J. Quack-
enbush, L. Zhou, E. Kirkness, S. Peterson, B. Loftus, D. Richardson,
R. Dodson, H. K. an A. Glodek, K. McKenney, L. Fitzegerald, N. Lee,
M. Adams, E. Hickey, D. Berg, J. Gocayne, T. Utterback, J. Peterson,
J. Kelley, M. Cotton, J. Weidman, C. Fuii, L. Watthey, E. Wallin,
W. Hayes, M. Borodovsky, P. Karp, H. Smith, C. Fraser, and J. Venter,
“The complete genome sequence of the gastric pathogen Helicobacter
pylori.” Nature, vol. 388, no. 6642, pp. 539 – 47, 1997.
[17] R. Alm, L. Ling, D. Moir, B. King, E. Brown, P. Doig, D. Smith, B. Noo-
nan, B. Guild, B. deJonge, G. Carmel, P.J.Tummino, A. Caruso, M. Uria-
Nickelsen, D. Mills, C. Ives, R. Gibson, D. Merberg, S. Mills, Q. Jiang,
D. Taylor, G. Vovis, and T. Trust, “Genomic-sequence comparison of two
unrelated isolates of the human gastric pathogen Helicobacter pylori.”
Nature, vol. 397, no. 6715, pp. 176 – 80, 1999.
[18] J. G. Martins, “Importaˆncia da fonte de carbono na produc¸a˜o de
plasmı´deos em culturas na˜o selectivas e de elevada densidade celular
de Escherichia coli.” Master’s thesis, Universidade Cato´lica Portuguesa,
2009.
[19] D. Naumann, “Some ultrastructural information on intact, living bacte-
rial cells and related cell-wall fragments as given by FTIR,” Infrared
Physics, vol. 24, no. 2-3, pp. 233 – 238, 1984.
